Summary
Extremely limited human data. All dosage and duration figures are extrapolated from user reports and close structural analogues (ฮฑ-PHP, ฮฑ-PVP, MDPV). Functions as a potent dopamine and norepinephrine transporter inhibitor; serotonin activity appears minimal. Acute risks include tachycardia, hypertension, vasoconstriction, hyperthermia, anxiety, paranoia, and rhabdomyolysis at high doses. Chronic use associated with insomnia, weight loss, compulsive use, psychosis, and cardiovascular strain.
Dose Information
Light
Common
Strong
Heavy
Onset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | After Effects |
|---|---|---|---|---|---|
| Oral | 15-45 min | 30-60 min | 1-2.5 hrs | 1-2 hrs | 6-24 hrs |
| Insufflated | 5-10 min | 10-20 min | 1-2.5 hrs | 1-2 hrs | 6-24 hrs |
| Smoked | 0-2 min | 5-15 min | 1-2.5 hrs | 1-2 hrs | 6-24 hrs |
Tolerance
Build-up
develops over days to weeks of regular use
Reset
3โ7 days for acute; 1โ3 weeks for full reset
Effects
Positive
- Stimulation
- Physical euphoria
Negative
- Bruxism
- Vasoconstriction
- Increased heart rate
- Increased blood pressure
- Sweating
- Insomnia
- Teeth grinding
- Increased perspiration
Positive
- Cognitive euphoria
- Focus enhancement
- Motivation enhancement
- Increased sociability
- Euphoria
Negative
- Compulsive redosing
- Anxiety
- Paranoia
- Cognitive fatigue
- Thought acceleration
Positive
- Increased libido
- Increased music appreciation
- Tactile enhancement
Negative
- Appetite suppression
- Light sensitivity
- Disinhibition
- Dehydration
- Appetite Suppression
- Vibrating vision
- Increase sexuality